DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Meclizine hydrochlorideis the generic ingredient in two branded drugs marketed by Casper Pharma Llc, Ivax Sub Teva Pharms, Nexgen Pharma Inc, Pliva, Abc Holding, Amneal Pharms, Anabolic, Ani Pharms Inc, Annora Pharma, Bundy, Epic Pharma Llc, Indicus Pharma, Invatech, Jubilant Cadista, Kv Pharm, Mylan Pharms Inc, Par Pharm, Rising, Sandoz, Superpharm, UDL, Vangard, Watson Labs, and Zydus, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.
There are seventeen drug master file entries for meclizine hydrochloride. Thirty-one suppliers are listed for this compound.
Recent Clinical Trials for meclizine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
|Mansoura University||Phase 1/Phase 2|
|Hospital Federal de Bonsucesso||Phase 4|
|Yvonne Sada||Phase 1|
Pharmacology for meclizine hydrochloride
|Drug Class||Antiemetic |
|Physiological Effect||Emesis Suppression |
Medical Subject Heading (MeSH) Categories for meclizine hydrochloride
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Vangard||MECLIZINE HYDROCHLORIDE||meclizine hydrochloride||TABLET;ORAL||087620-001||Jan 4, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Anabolic||MECLIZINE HYDROCHLORIDE||meclizine hydrochloride||TABLET;ORAL||085891-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Casper Pharma Llc||ANTIVERT||meclizine hydrochloride||TABLET;ORAL||010721-004||Approved Prior to Jan 1, 1982||AA||RX||Yes||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.